All cancer types, Secondary cancers
Results
Phase 1/2
This trial looked at a drug called BT1718 for people with , including cancers that had spread elsewhere in the body.
The trial was supported by Cancer Research UK. It was open for people to join between 2018 and 2023. The research team reported the results in 2024.
Recruitment start: 24 January 2018
Recruitment end: 8 March 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Udai Banerji
Cancer Research UK - regulatory@cancer.org.uk (trial sponsor )
The research team would like to thank all the patients who took part in this trial. By doing this, you’ve helped the research team learn more about cancer and how to treat it.
This is Cancer Research UK trial number CRUKD/17/009.
There is more information about this trial on the ISRCTN website (ISRCTN11160449): A Phase I/IIa trial of BT1718 in patients with advanced solid tumours
Last reviewed: 30 October 2024
CRUK internal database number: 15425
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
